Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=11
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=11
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=11
PubPharm (10.270)
101
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation : A Randomized, Open-label Study of High-Dose Vitamin D Versus Standard of Care Vitamin D Supplementation to Evaluate the Impact on Bone Health in Young Women With Early Stage Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
102
Cone Beam Breast CT for Breast Cancer Screening : Cone Beam Breast CT for Breast Cancer Screening
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
103
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials : Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
104
Study on TIL for the Treatment of Advanced Breast Cancer : A Clinical Study on TIL for the Treatment of Advanced Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
105
Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy : Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
106
Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test : Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
107
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer : A Phase 1B Trial Evaluating the Safety of Ribociclib, Tucatinib, and Trastuzumab in Patients With Metastatic, HER2+ Breast Cancer and a Multicenter, Randomized, Open-Label, Phase 2 Study of Preoperative Treatment With Ribociclib,Ttrastuzumab, Tucatinib, and Fulvestrant Versus Docetaxel, Carboplatin,Ttrastuzumab, and Pertuzumab in HR+/HER2+ Breast Cancer and Ribociclib, Trastuzumab, and Tucatinib Versus Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab in Patients With HR-/HER2+ Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
108
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) : A Phase 1 Clinical Study to Investigate the Safety and Pharmacokinetics of Tucatinib (MK-7119) in China Participants With HER2+ Advanced Breast Cancer, Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
109
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) : TACTIVE-U: An Interventional Safety and Efficacy Phase 1b/2, Open-label Umbrella Study to Investigate Tolerability, pk, and Antitumor Activity of Vepdegestrant (ARV-471/PF-07850327), an Oral Proteolysis Targeting Chimera, in Combination With Other Anticancer Treatments in Participants Aged 18 Years and Over With ER+ Advanced or Metastatic Breast Cancer, Sub-study A (ARV-471 in Combination With Abemaciclib)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
110
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer : A Multi-center, Multi-country Prospective Observational Study of Patients Initiating T-DXd in the First or Second Treatment Line for HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[1027]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Breast Neoplasms
Medienart
10.270
Aufsätze
10.270
E-Artikel
10.270
E-Ressourcen
Zeitschriftentitel
10.270
ClinicalTrials.gov
Thema
Breast Neoplasms
10.269
610
8.085
Study Type: Interventional
4.195
Recruitment Status: Completed
2.500
Medical Condition: Breast Cancer
2.491
Phase: Phase 2
2.352
Recruitment Status: Recruiting
2.104
Study Type: Observational
1.129
Recruitment Status: Active, not recruiting
950
Phase: Phase 3
916
Phase: Phase 1
826
Recruitment Status: Terminated
757
Triple Negative Breast Neoplasms
674
Recruitment Status: Unknown status
623
Recruitment Status: Not yet recruiting
524
Carcinoma
401
Neoplasms
345
Medical Condition: Metastatic Breast Cancer
341
Recruitment Status: Withdrawn
297
Phase: Phase 1, Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6.472
2020-
3.626
2010-2019
172
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10.270
Englisch
Haven't found what you're looking for?
Wird geladen...